Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial (Iran 2020-11-24) Multicenter RCT, IVM reduced mortality, low 02, and length of stay

TrumpLyftAlles | 1 points | Nov 24 2020 19:27:56

https://www.researchsquare.com/article/rs-109670/v1